Prioritisation of the human papillomavirus vaccine in a time of constrained supply

Lancet Child Adolesc Health. 2020 May;4(5):349-351. doi: 10.1016/S2352-4642(20)30038-9. Epub 2020 Feb 17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Developing Countries
  • Eligibility Determination
  • Female
  • Health Priorities
  • Health Services Accessibility
  • Humans
  • Male
  • Papillomavirus Vaccines / supply & distribution*
  • Papillomavirus Vaccines / therapeutic use*
  • Sex Factors
  • Uterine Cervical Neoplasms / prevention & control*
  • Young Adult

Substances

  • Papillomavirus Vaccines

Associated data

  • ClinicalTrials.gov/NCT03180034
  • ClinicalTrials.gov/NCT03675256